Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Loss of Smad4 drives vascular malformations via c-KIT–dependent high–fluid shear stress mimicry
Johannes Gahn, Fan Wu, Qing Zhang, Yuxi Di, Tanmaya Behera, Yonggang Ren, Zohrah Hashemi, Kuheli Banerjee, Julio Cordero, Claudia Gherman, Kornelia Andorfer, Caroline T. Seebauer, Fatemeh Mirzapour-Shafiyi, Gergana Dobreva, Martin A. Schwartz, Roxana Ola
Johannes Gahn, Fan Wu, Qing Zhang, Yuxi Di, Tanmaya Behera, Yonggang Ren, Zohrah Hashemi, Kuheli Banerjee, Julio Cordero, Claudia Gherman, Kornelia Andorfer, Caroline T. Seebauer, Fatemeh Mirzapour-Shafiyi, Gergana Dobreva, Martin A. Schwartz, Roxana Ola
View: Text | PDF
Research Article Cell biology Genetics Vascular biology

Loss of Smad4 drives vascular malformations via c-KIT–dependent high–fluid shear stress mimicry

  • Text
  • PDF
Abstract

Vascular endothelial cells (ECs) encode a homeostatic fluid shear stress (FSS) set point that is essential for vascular stability. Deviations above or below this threshold trigger adaptive remodeling to restore physiological shear levels. Disruption of this control mechanism leads to enlarged arteriovenous malformations (AVMs) in hereditary hemorrhagic telangiectasia, a vascular disorder caused by heterozygous loss-of-function (LOF) mutation in ALK1, ENG, or SMAD4. Mechanistically, Smad4-deficient ECs are reset to a lower FSS set point value, resulting in AVMs that show characteristics of high-FSS remodeling with elevated KLF4 and high activation of the downstream Akt. Here, we investigated the KLF4/Akt upstream mechanisms by which SMAD4 sets the physiological FSS set point. We identified the receptor tyrosine kinase c-KIT as a component and regulator of the junctional mechanosensory receptor complex, which is highly upregulated in murine and human AVMs. SMAD4 restrains flow signaling by limiting c-KIT–dependent ERK5 activation and KLF4 induction. Thus, SMAD4 LOF leads to sustained c-KIT engagement in the sensory junctional apparatus, driving enhanced and prolonged activation of the ERK5/KLF4/Akt signaling axis. These results show that Smad4-LOF mutations induce malformations by disabling a key homeostatic mechanism and identify c-KIT as a potentially previously unrecognized therapeutic target.

Authors

Johannes Gahn, Fan Wu, Qing Zhang, Yuxi Di, Tanmaya Behera, Yonggang Ren, Zohrah Hashemi, Kuheli Banerjee, Julio Cordero, Claudia Gherman, Kornelia Andorfer, Caroline T. Seebauer, Fatemeh Mirzapour-Shafiyi, Gergana Dobreva, Martin A. Schwartz, Roxana Ola

×

Figure 8

Inhibition of c-KIT kinase activity reverses AVM formation.

Options: View larger image (or click on image) Download as PowerPoint
Inhibition of c-KIT kinase activity reverses AVM formation.
(A) Schemati...
(A) Schematic of Tx administration (black arrowheads), DMSO or Avapritinib (Ava) treatment (blue arrowheads), and harvesting (red arrowhead) in Smad4fl/fl and Smad4iΔEC P6 neonates. (B) IB4 staining of Smad4iΔEC P6 retinas, DMSO versus Ava treated. (C) Quantification of AVMs’ number per retina in Smad4iΔEC DMSO- and Ava-treated neonates (n = 10 retinas/genotype). (D) Labeling for IB4 (red, upper panel) and IB4 (red), ERG (green), and KI67 (white) in lower panel of Smad4fl/fl and Smad4iΔEC retinas from DMSO- and Ava-treated neonates. (E) Quantification of retinal front vascular density in DMSO- and Ava-treated neonates (n = 6 retinas/genotype). (F) Quantification of KI67+ERG+ per total ERG+ ECs in vascular plexus capillaries of Smad4fl/fl and Smad4iΔEC retinas (n = 6–11 images from 3 retinas/group). (G) IB4 (green), ERG (white), and GOLPH4 (red) colabeling of P6 Smad4iΔEC retina explants isolated from DMSO- and Ava-treated neonates. (H) Quantification of EC polarization: against, with flow, and neutral (nonpolarized) in capillaries from P6 Smad4iΔEC retinas harvested from DMSO- and Ava-treated neonates (n = 2 images per retina from 3 retinas/group). Scale bars: 100 μm in B, 50 μm in D and G, and 20 μm in the insets in D and G. Yellow arrowheads in D indicate AVMs. Arrows in G indicate direction of EC migration. a, artery; v, vein. Data are represented as mean ± SEM. Student’s t test (C and H) and 2-way ANOVA (E and F) were used to determine statistical significance. **P < 0.01, ****P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts